May 19, 2016 – SARATOGA, Calif. – May 19, 2016 – CapsoVision, Inc., a Silicon Valley medical device innovator, announces that they have been recognized by Frost & Sullivan as the recipient of the 2016 European Enabling Technology Leadership award.
CapsoVision had previously been awarded by Frost & Sullivan for excellence in product differentiation in 2013.
“CapsoVision was chosen for this award because we continually invest in new technologies to deliver a unique and superior customer experience, and our innovative technologies across the entire CapsoCam system contribute in a meaningful way to towards the future of capsule endoscopy,” said Johnny Wang, CapsoVision President. “We are honored to receive this recognition.”
Frost & Sullivan has a global team of analysts and consultants continuously researching a wide range of markets across multiple sectors and geographies. As part of this ongoing research, they identify companies that continually invest in new technologies to deliver a unique and superior customer experience, or invest in technologies that enhance a vast array of applications. This research involves extensive primary and secondary research across the entire value chain of specific products.
“By working closely with physicians, the company ensures that its development efforts and new product generation match the needs of the marketplace,” said Frost & Sullivan Best Practices Analyst, Norma Vela. “With each innovation, CapsoVision refines its product design and technologies, thus closing the gaps in yield and accuracy for diagnostic performance.”